H. Chan

发表

Prediction of off-Treatment Response to Lamivudine by Serum Hepatitis B Surface Antigen Quantification in Hepatitis B E Antigen-Negative Patients

H. Chan, G. Wong, A. Chim, 2011, Antiviral therapy.

44 PERFORMANCE OF HEPATOCELLULAR CARCINOMA RISK SCORES IN CHRONIC HEPATITIS B PATIENTS RECEIVING ENTECAVIR TREATMENT

V. Wong, H. Chan, G. Wong, 2013 .

PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease

V. Wong, D. Yeung, J. Woo, 2015, Journal of gastroenterology and hepatology.

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers.

V. Wong, F. Chan, D. Yeung, 2012, Journal of hepatology.

Hepatitis B virus infection and fatty liver in the general population.

V. Wong, F. Chan, D. Yeung, 2012, Journal of hepatology.

The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil

V. Wong, Dongliang Yang, H. Chan, 2015, Journal of viral hepatitis.

Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment.

V. Wong, J. Sung, H. Chan, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.

V. Wong, F. Chan, J. Sung, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Evaluation of Alanine Transaminase and Hepatitis B Virus DNA to Predict Liver Cirrhosis in Hepatitis B e Antigen-Negative Chronic Hepatitis B Using Transient Elastography

V. Wong, F. Chan, J. Sung, 2008, The American Journal of Gastroenterology.

Antiviral Drug Resistance Testing in Patients with Chronic Hepatitis B

V. Wong, H. Chan, S. Locarnini, 2011, Digestive Diseases and Sciences.

Treatment of Patients with Chronic Hepatitis B who have Failed Previous Antiviral Treatment with Pegylated Interferon α2a (40 kDa; PEGASYS®)

J. Sung, G. Wong, A. Chim, 2008, Antiviral therapy.

Virological Response to Different Combination Regimes of Peginterferon α-2b and Lamivudine in Hepatitis B e Antigen Positive Chronic Hepatitis B

V. Wong, G. Wong, P. Choi, 2007, Antiviral therapy.

236 Genotype C hepatitis B virus infection is associated with increased risk of hepatocellular carcinoma. A prospective cohort study

V. Wong, J. Sung, M. Wong, 2004 .

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Jun Yu, 2010, Gut.

High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Jun Yu, 2009, International journal of cancer.

423 A randomized trial of peginteferon alfa-2B and lamivudine combination treatment versus lamivudine monotherapy in Chinese patients with HBEAG-positive chronic hepatitis B

F. Chan, J. Sung, N. Leung, 2004 .

Combination of pegylated interferon and lamivudine is superior to lamivudine monotherapy in the treatment of chronic hepatitis B — a randomized trial

F. Chan, J. Sung, N. Leung, 2003 .

Quantitative Subtyping of Hepatitis B Virus Reveals Complex Dynamics of Ymdd Motif Mutants Development during Long-Term Lamivudine Therapy

C. Ding, G. Wong, Y. Lo, 2006, Antiviral therapy.

Long-Term Lamivudine Treatment is Associated with a Good Maintained Response in Severe Acute Exacerbation of Chronic Hbeag-Negative Hepatitis B

V. Wong, S. Tsang, G. Wong, 2005, Antiviral therapy.

Long-Term follow-up of Lamivudine Treatment in Patients with Severe Acute Exacerbation of Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B

V. Wong, F. Chan, S. Tsang, 2008, Antiviral therapy.

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Y. Liaw, J. Niu, E. Gane, 2012, Journal of viral hepatitis.

Efficacy of Entecavir Switch Therapy in Chronic Hepatitis B Patients with Incomplete Virological Response to Telbivudine

V. Wong, G. Wong, H. Chan, 2013, Antiviral therapy.

Predictors of relapse in chronic hepatitis B after discontinuation of anti‐viral therapy

V. Wong, Yan Liang, M. Su, 2011, Alimentary pharmacology & therapeutics.

Chronic hepatitis B is the major cause of liver cirrhosis and hepatocellular carcinoma in China and most parts of Asia

V. Wong, Yan Liang, M. Su, 2011 .

Durability of peginterferon alfa‐2b treatment at 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

V. Wong, A. Chan, G. Wong, 2010, Hepatology.

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

V. Wong, G. Wong, H. Chan, 2013, Hepatology.

Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven‐year follow‐up study

V. Wong, J. Wong, G. Wong, 2009, Journal of medical virology.

A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B

V. Wong, G. Wong, H. Chan, 2010, Hepatology.

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

V. Wong, J. Sung, G. Wong, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients.

V. Wong, G. Wong, H. Chan, 2011, The Journal of infectious diseases.

Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B.

V. Wong, J. Sung, G. Wong, 2011, Journal of hepatology.

Serum Hepatitis B Surface Antigen Kinetics in Severe Reactivation of Hepatitis B E Antigen Negative Chronic Hepatitis B Patients Receiving Nucleoside/Nucleotide Analogues

V. Wong, G. Wong, A. Chim, 2013, Antiviral therapy.

A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96

M. Buti, P. Marcellin, W. Seto, 2017 .

Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B.

Vincent Wai-Sun Wong, Grace Lai-Hung Wong, V. Wong, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: A prospective cohort study with paired transient elastography examination

V. Wong, G. Wong, H. Chan, 2013, Journal of gastroenterology and hepatology.

Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: A prospective cohort study with paired transient elastography examination

V. Wong, G. Wong, H. Chan, 2013, Journal of gastroenterology and hepatology.

Surrogate end points and long-term outcome in patients with chronic hepatitis B.

V. Wong, J. Sung, S. Tsang, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B

V. Wong, A. Chan, K. To, 2017, Journal of gastroenterology and hepatology.

Endotoxaemia is Associated with Histological Severity of Non-Alcoholic Fatty Liver Disease and may be Increased in Patients with the TM6SF2 Gene Variants

V. Wong, H. Chan, A. Chan, 2016 .

On‐treatment alpha‐fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir

Yee-Kit Tse, V. Wong, G. Wong, 2014, Hepatology.

Association of HLA‐B22 serotype with SARS‐CoV‐2 susceptibility in Hong Kong Chinese patients

A. Wu, Yuk-Lin Yung, M. Ng, 2020, HLA.

Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia

Chi-kong Li, K. Chan, T. Wan, 2023, Communications Biology.

Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B.

V. Wong, H. Chan, G. Wong, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.

V. Wong, G. Wong, H. Chan, 2013, Gastroenterology.

Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B

V. Wong, G. Wong, A. Chim, 2015, Journal of gastroenterology and hepatology.

Non-invasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B 1 Running title : LSM and Hui index predict survival in CHB

V. Wong, H. Chan, G. Wong, 2014 .

SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response

R. Wong, Yuk-Lin Yung, M. Ng, 2023, International journal of molecular sciences.

Interaction of Adipokines and Hepatitis B Virus on Histological Liver Injury in the Chinese

Jun Yu, A. Cheng, V. Wong, 2010, The American Journal of Gastroenterology.

HBsAg Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2A in Chronic Hepatitis B: Long-Term Results of a Global Randomized Controlled Trial

M. Buti, P. Marcellin, R. Mehta, 2016 .